Formulary
Abacavir with dolutegravir and lamivudine: Indications, Dosing, Side Effects and Interactions
Abacavir with dolutegravir and lamivudine clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Abacavir with dolutegravir and lamivudine: Indications, Dosing, Side Effects and Interactions
Abacavir with dolutegravir and lamivudine clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**HIV infection**
- **Adult** (By Mouth): (body-weight 40 kg and above) 1 tablet once daily.
**HIV infection for abacavir with dolutegravir and lamivudine**
- **Child 12-17 years (body-weight 40 kg and above)** (By mouth): 1 tablet once daily.
Renal impairment
For abacavir with dolutegravir and lamivudine Avoid if creatinine clearance less than 50 mL/minute (consult product literature). M See Prescribing in renal impairment .
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Abacavir with dolutegravir and lamivudine in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

